High incidence of erythromycin-resistant streptococci in Taiwan

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 844-846

  Wu, Jiunn Jong ^a   Lin, Ku Yuan ^a   Hsueh, Po Ren ^b   Liu, Jien Wei ^c,d   Pan, Hsin I ^a   Sheu, Shwu Meei ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROCOCCUS FAECALIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; STREPTOCOCCUS INFECTION; TAIWAN;

EID: 0030899539     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.844     Document Type: Article

References (23)

1. Alcaide, F., J. Carratala, J. Liñares, F. Gudiol, and R. Martin. 1995. In vitro activity of eight macrolide antibiotics and RP-59500 against viridans streptococci isolated from blood of neutropenic cancer patients, abstr. E51, p. 94. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Alcaide, F., J. Liñares, R. Pallares, J. Carratala, M. A. Benitez, F. Gudiol, and R. Martin. 1995. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob. Agents Chemother. 39:2243-2247.
3. Berkowitz, K., J. A. Regan, and E. Greenberg. 1990. Antibiotic resistance patterns of group B streptococci in pregnant women. J. Clin. Microbiol. 28:5-7.
4. Coonan, K. M., and E. L. Kaplan. 1994. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. J. 13:630-635.
5. Doern, G. V., M. J. Ferraro, A. B. Brueggemann, and K. L. Ruoff. 1996. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:891-894.
6. Gardner, S. E., M. D. Yow, L. J. Leeds, P. K. Thompson, E. O. Mason, and D. J. Clark. 1979. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am. J. Obstet. Gynecol. 135:1062-1065.
7. Hsueh, P. R., H. M. Chen, A. H. Huang, and J. J. Wu. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242.
8. Hsueh, P. R., H. M. Chen, Y. C. Lu, and J. J. Wu. 1996. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J. Formosan Med. Assoc. 95:29-36.
9. Istre, G. R., D. F. Welch, M. I. Marks, and N. Moyer. 1981. Susceptibility of group A beta-hemolytic streptococcus isolates to penicillin and erythromycin. Antimicrob. Agents Chemother. 20:244-246.
10. Lämmler, D., S. Schwarz, I. W. T. Wibanan, E. Ott, V. Bopp, and A. Martinez-Tagle. 1995. Comparison of streptococci of serological group B isolated from healthy carriers and active disease in Chile. J. Med. Microbiol. 42:161-164.
11. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
12. Libertin, C. R., F. Leal, and D. S. Stein. 1988. Group G streptococci: susceptibility patterns and the effect of the inoculum size and growth phase on the bactericidal activity of penicillin. Diagn. Microbiol. Infect. Dis. 9:33-40.
13. Martius, J. 1990. Review: prophylaxis of newborn sepsis caused by group B streptococci. Int. J. Exp. Clin. Chemother. 3:243-244.
14. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Phillips, G., D. Parratt, G. V. Orange, I. Harper, H. McEwan, and N. Young. 1990. Erythromycin-resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:723-724.
17. Potgieter, E., M. Carmichael, H. J. Koornhof, and L. J. Chalkley. 1992. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 11:543-546.
18. Rolston, K. V. I., J. L. LeFrock, and R. F. Schell. 1982. Activity of nine antimicrobial agents against Lancefield group C and group G streptococci. Antimicrob. Agents Chemother. 22:930-932.
19. Ruoff, K. L. 1995. Streptococcus, p. 299-307. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
20. Seppälä, H., A. Nissinen, Q. Yu, H. Jarvinen, S. Huovinen, T. Henniksson, E. Herva, S. E. Holm, M. Johkola, M. K. Katila, T. Klaukka, S. Kontiainen, and O. Liimatainen. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
21. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
22. Stingemore, N., G. R. J. Francis, M. Toohey, and D. B. McGechie. 1989. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med. J. Aust. 150:626-631.
23. Verhaegen, J., P. Goubau, L. Verbist, J. Glupcznski, M. Blogie, and E. Yourassowsky. 1988. Erythromycin-resistant Streptococcus pneumoniae. Lancet ii:1432-1433.